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Abstract 
Objectives: To assess the perinatal outcomes of fetuses affected by heterotaxy. 
Methods: Medline, Embase and Cinhal were searched. Only studies reporting a prenatal diagnosis 
of isomerism were included. The outcomes observed were: associated cardiac and extra-cardiac 
anomalies, fetal arrhythmias, abnormal karyotype, type of surgical repair and perinatal mortality. 
The analysis was stratified according the type of heterotaxy syndrome (left, LAI, and right, RAI, 
atrial isomerism).  Meta-analyses of proportions were used to combine data. 
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Results: 16 studies (647 fetuses) were included. Atrioventricular septal defect (AVSD) was the 
most common associated major cardiac anomaly found in fetuses with LAI (Pooled Proportion 
[PP] 59.3%, 95% CI 44.0-73.7), while obstructive lesions of the right outflow tract occurred in 
35.5% (95% CI 21.4-51.0). Fetal arrhythmias occurred in 36.7% (95% CI 26.9-47.2) of the cases 
and were mainly represented by complete atrio-ventricular block (26.5%, 95% CI 15.0-40.0). 
Abnormal stomach and liver position were found in 59.4% (95% CI 38.1-79.0) and 32.5% (95% 
11.9-57.6) of cases, while intestinal malrotation was detected in 14.2% (95% CI 2.5-33.1). Hydrops 
developed in 11.8% (95% CI 2.9-25.6) of these fetuses. Biventricular repair was accomplished in 
78.2% (95% CI 64.3-89.4) of the cases while univentricular repair or palliation was needed for 
17.0% (95% CI 9.7-25.9). Death during or after surgery occurred in 26.8% (95% CI 4.6-58.7) of 
cases. 
Almost all (99.0% 95% CI 97.5-99.9) cases with RAI had associated cardiac anomalies, with 
AVSD being the most common heart defect (PP 72.9%, 95% CI 60.4-83.7). Abnormal heart 
rhythm was not common with an incidence of 1.3% (95% CI 0.2-3.2). Abnormal stomach and liver 
position were found in 54.5% (95% CI 38.5-70.1) and 45.9% (95% CI 11.3-83.0) of cases, 
respectively, while intestinal malrotation was detected in 27.1% (95% CI 7.9-5.2). Most children 
with RAI had univentricular repair and 27.8% (95% CI 15.5-42.1) died during or after surgery. 
Conclusion: Fetal heterotaxy is affected by a high prevalence of cardiac and extra-cardiac 
anomalies. Approximately one quarter of these fetuses died during or after surgery. Abnormal heart 
rhythm, especially heart block is common in fetuses with LAI while is uncommon in RAI. 
Univentricular repair is common in RAI.  
 
 
 
 
Introduction 
Heterotaxy encompasses a wide spectrum of conditions characterized by an abnormal arrangement 
of thoraco-abdominal organs across the left-right axis of the heart, differing from complete situs 
solitus and inversus.1-4  
Although its precise nomenclature and classification is still under debate, heterotaxy is commonly 
referred with the term ‘‘isomerism’’ which describes a situation in which morphologically right or 
left structures are found on both sides of the body and it is the currently accepted term used to 
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describe hearts with isomeric atria and atrial appendages. Right atrial isomerism (RAI) is typically, 
but not invariably, associated with asplenia while left (LAI) with polysplenia (55%).2,5  
Associated major cardiac anomalies are the main determinant in anticipating the outcome of 
children affected by heterotaxy; however, even those presenting with isolated defects can 
experience short and long-term morbidities such as intestinal malrotation, biliary atresia, 
respiratory and immune disorders.6-9 
Assessment of thoraco-abdominal situs is an integral part of the sonographic screening 
examination of the fetal heart and has led to an increase in the prenatal diagnosis of heterotaxy.10  
Despite this, assessment of atrial morphology and spleen anatomy on prenatal ultrasound is 
challenging and it has still to be validated on the general population, while lung lobulation cannot 
be reliably described in utero.11,12  
In this scenario, prenatal diagnosis of fetal heterotaxy relies mainly on the identification of cardiac 
and extra-cardiac defects commonly reported to be associated with these anomalies post-natally. 
Interruption of inferior vena cava (IVC) with azygos continuation is usually considered a proxy of 
LAI, while juxtaposition of aorta and IVC in fetuses presenting with major congenital heart 
disease (CHD) is highly suggestive of RAI. 
Paediatric literature reports high rates of associated cardiac and extra-cardiac anomalies in children 
affected by heterotaxy.1,13,14 However, these series might be biased by the fact that only 
symptomatic children or those requiring surgery are included, and it is not entirely certain whether 
they can be used to counsel parents carrying a pregnancy affected by these defects. 
The first aim of this systematic review was to evaluate the prevalence and the type of associated 
anomalies in fetuses with heterotaxy diagnosed on prenatal ultrasound; the secondary aim was to 
explore the perinatal outcome in these fetuses.   
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Methods 
 
Protocol, eligibility criteria, information sources and search 
This review was performed according to an a-priori designed protocol and recommended for 
systematic reviews and meta-analysis15-18. Medline, Embase and Cinhal were searched 
electronically on the 20th December 2016 utilizing combinations of the relevant medical subject 
heading (MeSH) terms, key words, and word variants for “isomerism”, “heterotaxy,” 
“cardiosplenic syndromes”, and “outcome” (Supplementary Material Table 1). The search and 
selection criteria were limited to the last two decades (1996-2016) and restricted to English 
language. Reference lists of relevant articles and reviews were hand searched for additional reports. 
Prisma guidelines were followed.19 The review was registered with the PROSPERO (registration 
number: CRD 42016053972, http://www.crd.york.ac.uk/PROSPERO).  
 
Study selection, data collection and data items 
The outcomes observed were: 
• Associated cardiac anomalies  
• Associated fetal arrhythmias 
• Associated extra-cardiac anomalies  
• Abnormal karyotype 
• Termination of pregnancy (TOP) 
• Intra-uterine death (IUD) 
• Neonatal death (NND) 
• Late death (LD) 
• Need for uni- or bi-ventricular repair and associated intra and post-surgical mortality 
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All these outcomes were observed in fetuses with LAI and RAI separately. For the assessment of 
the associated cardiac anomalies, we explore the prevalence of the following defects: atrio-
ventricular septal defect (AVSD), atrial septal defect (ASD) or common atrium, ventricular septal 
defect (VSD), single ventricle, left ventricular outflow tract obstruction (LVOTO), including either 
aortic stenosis or atresia, coarctation of aorta (CoA), right ventricular outflow tract obstruction 
(RVOTO), including either pulmonary stenosis or atresia, cono-truncal anomalies, including either 
Tetralogy of Fallot, double outlet right or left ventricle and common arterial trunk, transposition of 
the great arteries (TGA) including complete or congenitally corrected TGA and malposition, 
persistent left superior vena cava (PLSVC), interruption of IVC with azygos continuation, 
abnormal pulmonary venous return (APVR), including either the partial and total types of the 
anomaly, dextrocardia, defined as an abnormal cardiac axis pointing to the right, and arrhythmias.  
For the assessment of the associated extra-cardiac anomalies we explored the prevalence of the 
following defects: polysplenia, asplenia, abnormal stomach and liver position, intestinal 
obstruction and malrotation, abnormalities of the hepatobiliary tract, hydrops, abdominal wall 
defects, central nervous system (CNS), thoracic, facial, renal, limb and spinal anomalies. 
The prevalence of abnormal karyotype was observed only in the fetuses which had their full 
karyotype tested, either pre-or post-natally. Finally, the need for uni- or biventricular repair and the 
associated intra and post-surgical mortality were assessed only in liveborn infants. 
IUD was defined as fetal loss from 20 weeks of gestation, while NND and LD as a demise 
occurring within and after 28 days of life, respectively. 
Only studies reporting a prenatal diagnosis of LAI or RAI were considered suitable for the 
inclusion in the current systematic review. Post-natal studies or studies from which cases 
diagnosed pre-natally could not be extracted were excluded. Studies reporting fetal isomerism in 
the setting of a specific cardiac or extra-cardiac anomalies were not considered suitable for 
inclusion. Autopsy based studies were excluded on the basis that fetuses undergoing TOP are more 
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likely to show associated major structural and chromosomal anomalies. Finally, studies not 
providing a clear classification of the anomaly and studies not differentiating between LAI and 
RAI were not considered suitable for inclusion in the current review. The wide heterogeneity in 
nomenclature among published studies resulted in heterogeneity in risk stratification of these 
fetuses, therefore we included only studies providing a definition of the anomaly in accordance 
with that reported above. 
Only full text articles were considered eligible for the inclusion. Case reports, conference abstracts 
and case series with fewer than 3 cases of isomerism were also excluded in order to avoid 
publication bias. 
Studies were assessed according to the following criteria: population, outcome, type of heterotaxy 
syndrome and time at a follow-up. 
Two authors (DB, FD) reviewed all abstracts independently. Agreement regarding potential 
relevance was reached by consensus. Full text copies of those papers were obtained and the same 
two reviewers independently extracted relevant data regarding study characteristics and pregnancy 
outcome. Inconsistencies were discussed by the reviewers and consensus reached by discussion 
with a third author. If more than one study was published for the same cohort with identical 
endpoints, the report containing the most comprehensive information on the population was 
included to avoid overlapping populations. For those articles in which information was not reported 
but the methodology was such that this information would have been recorded initially, the authors 
were contacted. 
Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale 
(NOS) for cohort studies; according to NOS, each study is judged on three broad perspectives: the 
selection of the study groups; the comparability of the groups; and the ascertainment outcome of 
interest.20  Assessment of the selection of a study includes the evaluation of the representativeness 
of the exposed cohort, selection of the non-exposed cohort, ascertainment of exposure and the 
demonstration that outcome of interest was not present at start of study. Assessment of the 
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comparability of the study includes the evaluation of the comparability of cohorts on the basis of 
the design or analysis. Finally, the ascertainment of the outcome of interest includes the evaluation 
of the type of assessment of the outcome of interest, length and adequacy of follow-up.20 According 
to NOS a study can be awarded a maximum of one star for each numbered item within the 
Selection and Outcome categories. A maximum of two stars can be given for Comparability.  
 
Risk of bias, summary measures and synthesis of the results 
We used meta-analyses of proportions to combine data.21 Funnel plots displaying the outcome rate 
from individual studies versus their precision (1/standard error) were carried out with an 
exploratory aim. Tests for funnel plot asymmetry were not used when the total number of 
publications included for each outcome was less than ten. In this case, the power of the tests is too 
low to distinguish chance from real asymmetry.22-24  
Between-study heterogeneity was explored using the I2 statistic, which represents the percentage 
of between-study variation that is due to heterogeneity rather than chance. A value of 0% indicates 
no observed heterogeneity, whereas I2 values of ≥ 50% indicate a substantial level of 
heterogeneity. A random effect model was used for all the analyses. 
All proportion meta-analyses were carried out using StatsDirect 2.7.9 (StatsDirect Ltd, 
Altrincham). 
 
 
 
 
 
 
Results 
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A total of 2307 articles were identified, 134 were assessed with respect to their eligibility for 
inclusion (Supplementary Material Table 2, excluded studies) and a total of 16 studies included in 
the systematic review (Figure 1).14,25-38 These 16 studies included 647 fetuses with a prenatal 
diagnosis of isomerism (61.7%, 95% CI 57.8-65.4 with LAI and 38.3%, 95% CI 34.6-42.2 with 
RAI) confirmed at birth. 
All studies included a relatively small number of cases and had different periods of follow-up. 
Most of the included studies showed an overall good rate with regard to the selection and 
comparability of the study groups and for the ascertainment of the outcome of interest. Their main 
weaknesses were their retrospective design, small sample size and the inclusion of high-risk 
populations. Furthermore, the relatively short period of follow-up after birth did not allow a 
precise estimation of the long-term outcome of these children, especially those not undergoing 
surgery immediately after birth. 
 
Synthesis of the results 
Left isomerism 
Associated cardiac anomalies 
Associated major cardiac anomalies occurred in 83.4% (95% CI 74.4-90.7; I2: 69.7%) of cases 
(Figure 2). AVSD was the most common associated cardiac defect with a prevalence of 59.3% 
(95% CI 44.0-73.7) in the overall population of fetuses with a prenatal diagnosis of LAI, while 
RVOTO and transposition or malposition of the great arteries occurred in 35.5% (95% CI 21.4-
51.0) and 11.0% (95% CI 5.0-18.8) of the cases, respectively. Cono-truncal anomalies, especially 
double outlet right ventricle (DORV), were found in 21.2% (95% CI 16.0-27.0) of LAI while 
LVOTO were less common (8.2%, 95% CI 3.7-14.21 and 4.6%, 95% CI 1.4-9.4 respectively). 
Anomalies of systemic veins such as PLSVC (PP: 28.5%, 95% CI 17.0-41.6) and interruption of 
IVC (PP: 89.2%, 80.5-95.5) occurred in the large majority of cases, while those of pulmonary 
venous return, either partial or total, were less common (PP: 9.9%, 95% CI 5.4-15.5) (Table 3). 
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Fetal arrhythmias occurred in 36.7% (95% CI 26.9-47.2) of all cases and was mainly represented 
by CAVB (PP: 26.5%, 95% CI (15.0-40.0) (Table 4). 
 
Associated extra-cardiac anomalies 
Abnormalities of visceral arrangement occurred in 55.4% (95% CI 35.1-74.8) of fetuses with a 
prenatal diagnosis of LAI. When excluding anomalies of the abdominal situs and gastrointestinal 
tract, the rate of associated extra-cardiac anomalies was 16.0% (95% CI 7.5-26.9). 
Abnormal stomach and liver position were found in 59.4% (95% CI 38.1-79.0) and 32.5% (95% 
11.9-57.6) of cases with LAI, while malformations of the biliary tract such of the biliary tract such 
as biliary atresia were found in 8.0% (95% CI 3.5-14.3) (Table 5). Obstructive lesions of the bowel 
occurred in 4.9% (95% CI 2.7-7.7) of cases while malrotation was found in 14.2% (95% CI 2.5-
33.1) 
Hydrops developed in 11.8% (95% CI 2.9-25.6) of these fetuses mainly due to the presence of 
complete atrioventricular block (CAVB) (Table 5). Polysplenia was detected after birth in 56.6% 
(95% CI 48.1-65.0) of cases (PP: 51.1%, 95% CI 38.9-63.3), while only 5.8% (95% 1.9-11.8) had 
asplenia (Table 5). 
Associated extra-cardiac anomalies involving other systems were less common (Table 5). Finally, 
the prevalence of chromosomal anomalies was 3.0% (95% CI 1.2-5.6). 
 
Perinatal outcome 
TOP was performed in 24.8% (14.9-36.2) of cases, while 6.7% (95% CI 3.9-10.2) of fetuses died 
in utero (Table 6). The majority of fetuses with a prenatal diagnosis of LAI (60.7%, 95% CI 44.3-
76.0) were born alive, while NND or late death occurred in 11.1% (95% CI 6.1-17.3) and 6.2% 
(95% CI 4.0-8.9) of the cases, respectively (Table 6). 
Surgical intervention for CHD took place in 73.4% (95% CI 44.4-94.3) of those cases who were 
born alive. Biventricular repair was accomplished in 78.2% (95% CI 64.3-89.4) of the cases, while 
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univentricular repair or palliation was needed for 17.0% (95% 9.7-25.9) of children. Overall, death 
during or after surgery occurred in 26.8% (95% 4.6-58.7) of cases (Table 7).  
 
Right isomerism 
Associated cardiac anomalies 
The large majority of fetuses with a prenatal diagnosis of RAI had associated cardiac anomalies 
(PP: 97.8%, 95% CI 95.3-99.4; I2: 11.9%) (Figure 2). AVSD was the commonest heart defect with 
a prevalence of 72.9% (95% CI 60.4-83.7) in the overall population of fetuses with a prenatal 
diagnosis of RAI, while RVOTO and cono-truncal anomalies (mainly DORV) occurred in 67.4% 
(95% CI 56.2-77.8) and 40.1% (95% CI 28.0-52.8) of cases, respectively (Table 3). Anomalies of 
IVC and pulmonary venous return were common, with a prevalence of 41.8% (95% CI 28.9-55.3) 
and 41.9% (95% CI 28.4-56.0) of cases, respectively (Table 3). 
Juxtaposition of aorta and IVC, which constitutes one of the main feature of prenatal diagnosis of 
RAI in utero, was found in 81.5% (95% CI 59.2-96.2) while interruption of IVC was less common 
(PP: 4.9, 95% CI 2.6-7.8) (Table 3). Abnormal heart rhythm was not common, with a prevalence of 
1.3% (95% CI 0.2-3.2) (Tables 3 and 4). 
 
Associated extra-cardiac anomalies 
Associated extra-cardiac anomalies occurred in 62.9% (95% CI 32.5-88.4; I2: 93.6%) of cases of 
fetal RAI; among the other structural abnormalities, those involving gastro-intestinal tract were 
common. Abnormal stomach and liver position were found in 54.5% (95% CI 38.5-70.1) and 
45.9% (95% CI 11.3-83.0) of fetuses with a prenatal diagnosis of RAI, respectively, while 
malformations of the biliary tract such as atresia were less common (Table 5). Intestinal 
malrotation occurred in 27.1% (95% CI 7.9-5.2) (Table 5). Asplenia was present in the large 
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majority of cases (PP: 87.6%, 95% CI 75.5-96.0) while polysplenia, a common feature of LAI, 
was rare (PP: 2.0%, 95% CI 0.4-4.8) (Table 5). 
Only a small proportion (PP: 3.7%, 95% CI 1.4-6.8) of fetuses with RAI presented with hydrops, 
likely as the result of the low incidence of CAVB (Table 5). Finally, 4.0% (95% CI 0.8-9.6) of 
cases had abnormal karyotype. 
 
Perinatal outcome 
About one third of pregnancies affected by RAI were terminated, while 4.3% (95% CI 2.1-7.3) 
experienced IUD (Table 6). Of those cases born alive, 17.6% (95% CI 8.7-28.7) and 14.7% (95% 
CI 7.9-23.1) of cases died during or after the neonatal period, respectively (Table 6). 
Surgical intervention for CHD was performed in 70.0% (95% CI 20.7-99.6) of children (Table 6). 
The large majority of those children required univentricular repair, while only in a small 
proportion of cases (PP: 7.4%, 95% CI 0.5-33.7) biventricular repair was accomplished (Table 7). 
Overall, 27.8% (95% CI 15.5-42.1) died during or after surgery. 
 
 
 
 
 
 
 
Discussion 
Main findings 
The findings from this systematic review show that fetuses with heterotaxy are affected by a high 
rate of associated cardiac and extra-cardiac anomalies. Abnormalities of atrio-ventricular valves 
are among the most common anomalies in fetal heterotaxy. Abnormal heart rhythm, especially 
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CAVB can occur in up to 25% of LAI and is responsible for the high rate of cases presenting with 
hydrops at an early gestational age during the pregnancy, while are rare in RAI. In cases 
undergoing surgery after birth, biventricular repair was common in LAI while the large majority of 
children affected by RAI required univentricular repair. Finally, intra- or post-surgical mortality 
was high in both LAI and RAI and occurred in about a quarter of these cases. 
 
Strengths and Limitations 
The small number of cases per each study, their retrospective design, different periods of follow-
up and inclusion criteria, with most of the series being from high risk population represent the 
major limitations of this systematic review. Unfortunately, the scarce number of studies did not 
permit meaningful stratified meta-analyses to explore the test performance in subgroups of studies 
that may be less or more susceptible to bias. The assessment of the potential publication bias was 
also problematic, both because of the outcome nature (rates with the left side limited to the value 
zero) which limits the reliability of funnel plots, and because of the scarce number of individual 
studies, which strongly limits the reliability of formal tests.  
Most of the studies included in the current review were from high risk populations. This might 
have led in turn to an over-estimation of the associated cardiac and extra-cardiac anomalies. 
Finally, the different times of follow-up and post-natal imaging protocols among the different 
studies might have biased the real occurrence of associated cardiac and extra-cardiac anomalies 
since some anomalies may manifest only later in childhood, while others can be easily overlooked 
at a standard clinical examination. 
Despite these limitations, however, the present review represents the best published estimate of a 
number of outcomes in fetuses diagnosed with isomerism.  
 
Interpretation of the findings, their Clinical and research implications  
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Routine assessment of the fetal situs is an integral part of the second trimester routine anomaly 
scan10 and has led to an increase in the detection rate of heterotaxy syndromes. Despite this, a 
precise characterization of the type of heterotaxy syndrome is not always feasible in utero.  
Autopsy studies have reported that morphology of the atrial appendages can reliably differentiate 
between LAI and RAI.39. Characterization of the morphology of the atrial appendage in utero has 
been reported to be feasible and can improve the detection of these anomalies especially when new 
ultrasound techniques such as four dimensional ultrasound are employed, but it may be 
challenging.11,31  
Prenatal diagnosis of heterotaxy on ultrasound mainly relies on the presence of associated cardiac 
and extra-cardiac anomalies which are typically reported to co-exist with isomerism. RAI is almost 
invariably associated with CHD, especially, con-truncal anomalies, RVOTO, transposition and 
hypoplastic left heart syndrome and it is affected by a generally worse perinatal outcome 
compared to RAI in view of the higher incidence of associated CHD. Furthermore, abnormal 
TPVR occurs in the large majority of fetuses with RAI and represents one the major determinants 
of post-natal outcome in these children, especially when obstructed. Conversely, interruption of 
IVC can be the only sign of LAI thus making prenatal diagnosis of this anomaly challenging, 
although it has also been also reported in fetuses not affected by isomerism40.  
Hydrops developed in approximately 10% of fetuses affected by LAI, mainly because of the 
presence of a CAVB, which can occur in up to 25% of cases. Fetal hydrops is one of the major 
determinants of poor perinatal outcome in fetuses with LAI and can be evident since the first 
trimester of pregnancy.41 CAVB was the most common fetal arrhythmias in fetuses with LAI and 
was associated with an high burden of perinatal mortality and morbidity; furthermore, CAVB in 
the setting of LAI can be associated with myocardial non compaction which is characterized by 
regional ventricular wall thickening and deep trabecular recesses and is almost invariably 
associated with a poor prognosis.42 
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Chromosomal anomalies are not common in heterotaxy; in the present review, abnormal karyotype 
was present in 3.0% (95% CI 1.2-5.6) of cases in LAI and 4.0% (95% CI 0.8-9.6) of cases with 
RAI. These figures might influence the parental decision whether to proceed with invasive 
prenatal diagnosis or not. 
Abnormalities of the biliary tract such as biliary atresia are typically associated with heterotaxy.  
Newborns with biliary atresia develop progressive cholestasis which may evolve towards 
irreversible cirrhosis and liver failure if untreated. Prompt recognition and treatment are 
fundamental to improve the outcome of these children.43,44  
Prenatal diagnosis of biliary atresia is challenging. Non-visualization of the fetal gallbladder, 
combined with the assessment of the amniotic fluid digestive enzymes, has been reported to have 
an overall good detection rate for biliary atresia. However, it requires validation in larger studies45-
48. In this scenario, fetuses suspected to be affected by heterotaxy should be referred for a detailed 
assessment of the hepatobiliary tract in order to rule out biliary atresia. Nevertheless, urgent post-
natal assessment should be performed in order to rule out this anomaly.43,44 
Intestinal malrotation has been variably associated with heterotaxy with a reported incidence 
ranging from 30% to 90% in the pediatric literature.49-51 Intestinal malrotation increases the risk of 
midgut volvulus, which can potentially result in significant bowel loss, intestinal insufficiency, and 
death.52,53 
A recent systematic review exploring the association between intestinal malrotation and heterotaxy 
reported a prevalence of 58% (95% CI 36%-78%) in children with heterotaxy undergoing 
screening for bowel anomalies, although there was a wide heterogeneity in screening regimens 
among the included studies.  
In the present review, intestinal anomalies occurred in 14.2% and 27.1% in LAI and RAI, 
respectively. However, there was a significant heterogeneity in the reported incidence due to the 
different screening policies for intestinal anomalies among the included studies.  
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Fetal magnetic resonance imaging is an important adjunct imaging modality to ultrasound and has 
been shown to provide an optimal anatomical characterization of the bronchial, hepatic, intestinal 
and splenic anatomy. In view of these findings, it might seem reasonable to refer cases of 
suspected  heterotaxy on ultrasound to undergo fetal MRI, in order to determine the spleen status 
and rule out associated abnormalities, such as biliary atresia and intestinal malrotation, which 
might influence the prognosis of children with heterotaxy.54,29,55  
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Table 1. General characteristics of the included studies. 
Author Year Country Study 
design 
Period 
analysed 
(year) 
GA at 
diagnosis 
(week) 
Heterotax
y 
Fetuse
s (n) 
Time at 
follow-up 
Gottschalk25 2016 Germany Retrospectiv
e 
1999-
2013 
24.0±6.7 LAI, RAI 165 29 months 
Gaur26 2016 United 
States 
Retrospectiv
e 
2008-
2013 
23.0±4.2 LAI, RAI 15 NS 
Escobar-
Diaz27 
2014 United 
States 
Retrospectiv
e 
1995-
2011
22 (19-30) LAI, RAI 154 5 years 
Lee28 2014 Korea Retrospectiv
e 
1999-
2011 
26.9 (16.5-
38.6) 
LAI, RAI 71 26.5 months 
(1-138) 
Nemec29 2012 Austria Retrospectiv
e 
2002-
2009 
NS LAI, RAI 5 NS 
Özkutlu30 2011 Turkey Retrospectiv
e 
1999-
2006 
29.2 (21-37) LAI, RAI 6 NS 
Paladini31 2011 Italy Retrospectiv
e 
2004-
2009 
22 (13-34) LAI, RAI 22 NS 
Pepes32 2009 United 
Kingdom 
Retrospectiv
e 
1998-
2008 
18 (12-29) LAI 41 NS 
Yan33 2008 Singapor
e 
Retrospectiv
e 
1998-
2005
21.3 (18-33) LAI, RAI 22 NS 
Taketazu34 2006 Canada Retrospectiv
e 
1992-
2002 
24.3±6.4 LAI, RAI 71 NS 
Pasquini35 2005 United 
Kingdom 
Prospective 1997-
2003 
25 (18-39) LAI, RAI 8 NS 
Lin14 2002 Taiwan Retrospectiv
e 
1994-
1998 
NS LAI, RAI 29 0-2 years 
Hoefstaetter3
6 
2000 Germany Retrospectiv
e 
1995-
2000 
22.2 (21-25) LAI, RAI 7 NS 
Abuhamad12 1999 United 
States 
Prospective 1995-
1998
20.1 (17.4-
24.4)
LAI, RAI 8 NS 
Atkinson37 1998 United 
States 
Retrospectiv
e 
1991-
1997 
26 (18-36) LAI, RAI 13 NS 
Phoon38 1996 United 
States 
Retrospectiv
e 
1990-
1994 
NS LAI 10 1-24 months 
GA: gestational age; NS: not specified; LAI: left atrial isomerism; RAI: right atrial isomerism 
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Table 2. Quality assessment of the included studies according to Newcastle-Ottawa Scale (NOS) a 
study can be awarded a maximum of one star for each numbered item within the Selection and 
Outcome categories. A maximum of two stars can be given for Comparability. 
Author Year Selection Comparability Outcome 
Gottschalk25 2016    
Gaur26 2016    
Escobar-Diaz27 2014    
Lee28 2014    
Nemec29 2012    
Özkutlu30 2011    
Paladini31 2011    
Pepes32 2009    
Yan33 2008    
Taketazu34 2006    
Pasquini35 2005    
Lin14 2002    
Hoefstaetter36 2000    
Abuhamad12 1999    
Atkinson37 1998    
Phoon38 1996    
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Table 3. Pooled proportions (PP) for the prevalence of associated intra-cardiac anomalies (ICA) 
anomaly in fetuses with left atrial isomerism (LAI) and right atrial isomerism RAI. 
ICA Studies Fetuses 
(n/N) 
PP (95% 
CI) 
I2 
(%) 
 Studies Fetuses 
(n/N) 
PP (95% 
CI) 
I2 
(%) 
 Left isomerism   Right isomerism 
AVSD 15 205/386 59.28 
(44.0-73.7) 
85.5  13 180/246 72.86 
(60.4-83.7 
70.3 
VSD 13 27/233 10.99 (3.1-
22.9) 
77.2  12 4/193 2.65 (0.9-
5.3) 
0 
ASD 13 22/233 19.61 (6.8-
37.0) 
85.2  12 36/193 21.49 (2.8-
50.9) 
94.0 
Single ventricle 13 56/347 13.76 (6.5-
23.3) 
71.8  12 104/238 37.84 
(18.1-60.0) 
89.9 
LVOTO 15 35/386 8.17 (3.7-
14.21) 
59.4  13 18/246 6.91 (3.5-
11.3) 
21.8 
CoA 15 18/386 4.57 (1.4-
9.4) 
58.8  13 5/246 3.01 (1.3-
5.54) 
0 
RVOTO 15 108/386 35.49 
(21.4-51.0) 
86.3  13 173/246 67.43 
(56.2-77.8) 
61.3 
Cono-truncal 
anomalies 
15 75/386 21.23 
(16.0-27.0) 
26  13 109/246 40.06 
(28.0-52.8) 
68.2 
TGA 15 36/386 10.98 (5.0-
18.8) 
70.1  13 42/246 21.33 
(10.9-34.1) 
74.8 
PLSVC 13 109/341 28.49 
(17.0-41.6) 
77.8  12 100/221 41.80 
(28.9-55.3) 
67.2 
Interrupted IVC 15 336/386 89.15 
(80.5-95.5) 
75.4  13 11/246 4.86 (2.6-
7.8) 
0 
Juxtaposition 
Ao/IVC 
15 2/386 1.19 (0.3-
2.5) 
0  9 127/173 81.50 
(59.2-96.2) 
89.1 
TAPVR 15 30/381 9.85 (5.4-
15.5) 
48.4  13 102/234 41.87 
(28.4-56.0) 
72.9 
Dextrocardia 11 65/262 25.87 
(13.3-40.9) 
77.6  12 57/239 24.25 
(10.4-41.6) 
85.1 
Arrhythmias 13 123/378 36.73 
(26.9-47.2) 
66.9  10 2/218 1.30 (0.2-
3.2) 
0 
AVSD: atrio-ventricular septal defect; VSD: ventricular septal defect; ASD: atrial septal defect; 
LVOTO: left ventricular outflow tract obstruction; CoA: coarctation of aorta; RVOTO: right 
ventricular outflow tract obstruction; TGA: transposition of the great arteries; PLSVC: persistent 
left superior vena cava; IVC: inferior vena cava; Ao: aorta; TAPVR: Total anomalous pulmonary 
venous return 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
 
 
Table 4. Pooled proportions (PP) for the prevalence of associated cardiac arrhythmias in fetuses 
with left atrial isomerism (LAI) and right atrial isomerism RAI. 
 Studi
es 
Fetuses 
(n/N) 
PP (95% 
CI) 
I2 
(%) 
 Studi
es 
Fetuses 
(n/N) 
PP 
(95% 
CI) 
I2 
(%) 
 Left isomerism   Right isomerism 
Arrhythmias 
(overall) 
13 123/378 36.73 
(26.9-
47.2) 
66.9  10 2/218 1.30 
(0.2-
3.2) 
0 
AVB (overall) 11 96/367 28.82 
(16.9-
42.5) 
82.3  9 1/216 1.14 
(0.1-
3.0) 
0 
I degree AVB 11 0/367 0 (0-1.5) 0  9 0/216 0 (0-
2.4) 
0 
II degree AVB 11 2/367 0.72 (0.1-
1.9) 
0  9 0/216 0 (0-
2.4) 
0 
III Degree AVB 
(CAVB) 
11 93/367 26.51 
(15.0-
40.0) 
82.5  9 1/216 1.14 
(0.1-
3.0) 
0 
Tachycardia 11 5/367 1.64 (0.3-
4.2) 
41  9 0/216 0 (0-
2.4) 
0 
AVB: atrioventricular block; CAVB: complete AVB 
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Table 5. Pooled proportions (PP) for the prevalence of associated extra-cardiac anomalies (ECA) anomaly in fetuses with left atrial isomerism 
(LAI) and right atrial isomerism RAI. 
ECA Studies Fetuses 
(n/N) 
PP (95% CI) I2 (%)  Studies Fetuses 
(n/N) 
PP (95% CI) I2 (%) 
 Left isomerism  Right isomerism 
Polysplenia 10 134/236 56.63 (48.1-
65.0) 
65.3  9 2/159 2.03 (0.4-4.8) 0 
Asplenia 9 14/226 7.14 (2.1-14.9) 60  9 138/159 87.59 (75.5-96.0) 69.4 
Abnormal stomach position 8 37/65 59.39 (38.1-
79.0) 
58.7  7 44/76 54.53 (38.5-
70.1) 
36.8 
Abnormal liver position 6 24/53 32.54 (11.9-
57.6) 
68.5  7 50/76 45.89 (11.3-83.0) 90.1 
Abnormal hepatobiliary tract 9 17/278 8.02 (3.5-14.3) 46.7  9 5/179 3.75 (0.5-9.8) 54.6 
Intestinal malrotation 9 46/278 14.21 (2.5-33.1) 90.2  9 47/179 27.12 (7.9-52.0) 90.5 
Gastrointestinal obstruction 9 12/278 4.91 (2.7-7.7) 0  9 6/179 3.97 (1.6-7.3) 0 
Hydrops 11 45/258 11.76 (2.9-25.6) 83.4  10 6/180 3.67 (1.4-6.8) 0 
Central nervous system anomalies 9 4/249 2.43(0.9-4.7) 0  9 3/143 2.77 (0.7-6.0) 0 
Facial anomalies 9 3/249 1.57 (0.3-3.9) 10  8 1/120 1.45 (0.1-4.3) 0 
Thoracic anomalies 9 2/249 1.10 (0.2-2.7) 0  8 1/120 1.92 (0.3-5.1) 0 
Abdominal wall defects 9 1/249 0.97 (0.1-2.5) 0  8 2/120 2.38 (0.4-5.8) 0 
Limb anomalies 9 0/249 0 (0-1.8) 0  8 2/120 2.44 (0.2-7.2) 0 
Kidney anomalies 9 7/249 3.24 (0.6-7.8) 37.8  8 3/120 3.43 (1.0-7.3) 0 
Spine anomalies 9 2/249 1.10 (0.2-2.7) 0  8 0/120 0 (0-3.7) 0 
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Table 6. Pooled proportions (PP) for the prevalence of abnormal perinatal outcome in fetuses affected with left atrial isomerism (LAI) and right 
atrial isomerism RAI. 
 Studies Fetuses 
(n/N) 
PP (95% CI) I2  Studies Fetuses 
(n/N) 
PP (95% CI) I2 
 Left isomerism  Right isomerism 
Termination of the 
pregnancy 
15 99/380 24.79 (14.9-
36.2) 
76.2  13 77/238 33.46 (22.6-45.3) 63.3 
Intrauterine death 15 25/380 6.73 (3.9-10.2) 19.4  13 9/238 4.32 (2.1-7.3) 1.7 
Neonatal death 14 34/668 11.12 (6.1-17.3) 50.1  11 36/232 17.55 (8.7-28.7) 69.4 
Late death 13 21/365 6.24 (4.0-8.9) 0  11 37/232 14.69 (7.9-23.1) 54.3 
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Table 7. Pooled proportions (PP) for the prevalence of abnormal surgical outcome in fetuses affected with left atrial isomerism (LAI) and right 
atrial isomerism RAI. 
 Studies Fetuses (n/N) PP (95% CI) I2  Studies Fetuses (n/N) PP (95% CI) I2 
 Left isomerism  Right isomerism 
Need for surgery 3 82/109 73.43 (44.4-94.3) 82.9 3 41/62 70.06 (20.7-99.6) 93.1
Biventricular repair 2 64/80 78.16 (64.3-89.4) 34.6  2 3/39 7.42 (0.5-33.7) 79.3 
Univentricular repair 2 13/80 17.03 (9.7-25.9) 0  2 36/39 92.60 (66.3-99.5) 79.3 
Deaths during or after 
surgery 
3 11/82 26.80 (4.6-58.7) 78.3  3 11/41 27.81 (15.5-42.1) 27.0 
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Figure Legends 
 
Figure 1: FLOW CHART 
 
Figure 2: Pooled Proportions for the occurence of Intracardiac Anomalies (ICA)   
 
Figure 3: Pooled Proportions for the occurence of Arrhythmias 
Figure 4: Pooled Proportions for the occurence of Extracardiac Anomalies (ECA) 
Figure 5: Pooled Proportions for the occurence of Intrauterine Death (IUD) 
Figure 6: Pooled Proportions for the occurence of Neonatal Death (NND) 
 
 
 
 
 
 
  
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
 
 
Figure 1 FLOW CHART 
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Figure 3 Pooled Proportions for the occurence of Arrhythmias  
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Figure 4 Pooled Proportions for the occurence of Extracardiac Anomalies (ECA)   
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Figure 5 Pooled Proportions for the occurence of Intrauterine Death (IUD)  
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Figure 6 Pooled Proportions for the occurence of Neonatal Death (NND)    
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